Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice. Local targets link to admitted publications; unresolved targets remain external evidence.
Origin and evolution of pathogenic coronaviruses
10.1038/s41579-018-0118-9 · 2019 · External reference
Characteristics of SARS-CoV-2 and COVID-19
10.1038/s41579-020-00459-7 · 2021 · External reference
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
10.1056/nejmoa2035389 · 2021 · External reference
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
10.1056/nejmoa2034577 · 2020 · External reference
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 · External reference
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
10.1126/science.abm0271 · 2022 · External reference
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
10.1038/s41541-021-00292-w · 2021 · External reference
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
10.1038/s41392-021-00644-x · 2021 · External reference
SARS-CoV-2 variants, spike mutations and immune escape
10.1038/s41579-021-00573-0 · 2021 · External reference
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
10.1056/nejmoa2108891 · 2021 · External reference
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
10.1016/j.cell.2020.06.035 · 2020 · External reference
A Thermostable mRNA Vaccine against COVID-19
10.1016/j.cell.2020.07.024 · 2020 · External reference
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
10.1038/s41467-021-21037-2 · 2021 · External reference
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
10.1016/j.immuni.2020.07.019 · 2020 · External reference
An mRNA Vaccine against SARS-CoV-2 ‐ Preliminary Report
10.1056/nejmoa2022483 · 2020 · External reference
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA
10.1016/j.immuni.2005.06.008 · 2005 · External reference
Lipid-based nanoparticle formulations for small molecules and RNA drugs
10.1080/17425247.2019.1669558 · 2019 · External reference
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
2018 · External reference
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
10.1038/334255a0 · 1988 · External reference
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
10.1016/j.cell.2021.04.006 · 2021 · External reference
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
10.1016/j.cell.2021.02.037 · 2021 · External reference
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
10.1126/science.abl8506 · 2021 · External reference
